Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - INTEREST INCOME & EXPENSE
Interest Income & Expense OCX - OncoCyte Corporation
52 K
LAST VALUE
-50.12%
2 YEAR CAGR
-24.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR